Dexamethasone up-regulates the inhibitory adaptor protein Dok-1 and suppresses downstream activation of the mitogen-activated protein kinase pathway in antigen-stimulated RBL-2H3 mast cells

Molecular Pharmacology

Volumn 67, Issue 3, 2005, Pages 598-603

  Hiragun, Takaaki ^a,b   Peng, Ze ^a   Beaven, Michael A ^a,c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ARACHIDONIC ACID; CYTOKINE; DEXAMETHASONE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; GENE OVEREXPRESSION; GENE REPRESSION; INHIBITION KINETICS; MAST CELL; MAST CELL DEGRANULATION; MAST CELL LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIGENS; ARACHIDONIC ACID; BASE SEQUENCE; CELL LINE, TUMOR; DEXAMETHASONE; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; KINETICS; MAP KINASE SIGNALING SYSTEM; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; RATS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 14944347295     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.008607     Document Type: Article

References (24)

1. Dok and SHIP and affects RBL-2H3 cell cycle. Immunol Lett 82:23-28.
2. Abramson J, Rozenblum G, and Pecht I (2003) Dok protein family members are involved in signaling mediated by the type 1 Fcε receptor. Eur J Immunol 33:85-91.
3. Adcock IM (2001) Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 14:211-219.
4. Andrade MV, Hiragun T, and Beaven MA (2004) Dexamethasone suppresses antigen-induced activation of phosphatidylinositol 3-kinase and downstream responses in mast cells. J Immunol 172:7254-7262.
5. Bazuine M, Carlotti F, Tafrechi RS, Hoeben RC, and Maassen JA (2004) Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 18:1697-1707.
6. dok: a constitutively tyrosine- phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197-204.
7. Choi WS, Kim YM, Combs C, Frohman MA, and Beaven MA (2002) Phospholipase D1 and 2 regulate different phases of exocytosis in mast cells. J Immunol 168:5682-5689.
8. Cissel DS and Beaven MA (2000) Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J Biol Chem 275:7066-7070.
9. Collado-Escobar D, Cunha-Melo JR, and Beaven MA (1990) Treatment with dexamethasone down-regulates IgE-receptor mediated signals and up-regulates adenosine-receptor mediated signals in a rat mast cell (RBL-2H3) line. J Immunol 144:244-250.
10. Engelbrecht Y, de Wet H, Horsch K, Langeveldt CR, Hough FS, and Hulley PA (2003) Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines. Endocrinology 144:412-422.
11. Hayashi R, Wada H, Ito K, and Adcock IM (2004) Effects of glucocorticoids on gene transcription. Eur J Pharmacol 500:51-62.
12. Jeong HJ, Na HJ, Hong SH, and Kim HM (2003) Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 144:4080-4086.
13. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, and Cato AC (2001) Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO (Eur Mol Biol Organ) J 20:7108-7116.
14. Kepley CL, Taghavi S, Mackay GA, Zhu D, Morel PA, Zhang K, Ryan JJ, Satin LS, Zhang M, Pandolfi PP, et al. (2004) Co-aggregation of FcγRII with FcεRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. J Biol Chem 279:35139-35149.
15. Lasa M, Abraham SM, Boucheron C, Saklatvala J, and Clark AR (2002) Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol 22:7802-7811.
16. dok, is a mediator of FcγIIB inhibition of FcεRI signaling. J Immunol 168:4430-4439.
17. Rider LG, Hirasawa N, Santini F, and Beaven MA (1996) Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J Immunol 157:2374-2380.
18. Rivera J (2002) Molecular adapters in FcεRI signaling and the allergic response. Curr Opin Immunol 14:688-693.
19. Schacke H and Rehwinkel H (2004) Dissociated glucocorticoid receptor ligands. Curr Opin Investig Drugs 5:524-528.
20. Shah K and Shokat KM (2002) A chemical genetic screen for direct V-Src substrates reveals ordered assembly of a retrograde signaling pathway. Chem Biol 9:35-47.
21. Shinohara H, Yasuda T, and Yamanashi Y (2004) Dok-1 tyrosine residues at 336 and 340 are essential for the negative regulation of Ras-Erk signalling, but dispensable for RasGAP-binding. Genes Cells 9:601-607.
22. Tamir I, Stolpa JC, Helgason CD, Nakamura K, Bruhns P, Daeron M, and Cambier JC (2000) The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 12:347-358.
23. Veillette A, Latour S, and Davidson D (2002) Negative regulation of immunoreceptor signaling. Annu Rev Immunol 20:669-707.
24. Zhang C, Baumgartner RA, Yamada K, and Beaven MA (1997) Mitogen activated protein (MAP) kinase regulates production of TNFα and release of arachidonic acid in mast cells: indications of communication between p38 and p42 MAP kinases. J Biol Chem 272:13397-13402.